Unknown

Dataset Information

SARS-CoV-2 rapid antigen tests provide benefits for epidemic control - observations from Austrian schools.


ABSTRACT:

Objective

This paper motivates and justifies the use of antigen tests for epidemic control as distinct from a diagnostic test.

Study design and setting

We discuss the relative advantages of antigen and PCR tests, summarizing evidence from both the literature as well as Austrian schools, which conducted frequent, mass rapid antigen testing during the spring of 2021. While our report on testing predates Delta, we have updated the review with recent data on viral loads in breakthrough infections and more information about testing efficacy, especially in children.

Results

Rapid antigen tests detect proteins at the surface of virus particles, identifying the disease during its infectious phase. In contrast, PCR tests detect viral genomes: they can thus diagnose COVID-19 be

SUBMITTER: Polechova J 

PROVIDER: S-EPMC8760838 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature